Ether

Ether

SCHEMBL9686183

CCOCC.F.F.[F-].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL797466 0.95
Ether SCHEMBL27134483 0.91 ALDH1A1 (0.39)
Ether SCHEMBL699018 0.91
Ether SCHEMBL310584 0.91
Ether SCHEMBL811889 0.91 ALDH1A1 (0.44)
Ether SCHEMBL351216 0.91
Ether SCHEMBL21816757 0.86 ALDH1A1 (0.41)
Ether SCHEMBL21326457 0.86
Ether SCHEMBL421875 0.86
Ether SCHEMBL9750539 0.86 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0264124-B1 QUINOLINE BASE COMPOUND, PROCESS FOR THE PREPARATION THEREOF AND ANTICANCER AGENT CONTAINING THE SAME AS PHARMACOLOGICALLY EFFICACIOUS COMPONENT MECT CORPORATION (JP) 1992-03-11 EP disclosed
US-4826850-A Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component MECT CORPORATION (JP) 1989-05-02 US disclosed
EP-0264124-A1 Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component MECT CORPORATION (JP) 1988-04-20 EP disclosed